Direct fast track admission to a coronary care unit

Journal of the Royal College of Physicians of London

Volumn 31, Issue 2, 1997, Pages 193-197

  Thomas, David ^a   Cooper, Leanne ^a   Cooper, Julie ^a   Taylor, Deborah ^a   Robb, Alex ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CORONARY CARE UNIT; FEMALE; FIBRINOLYTIC THERAPY; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; THORAX PAIN; VOCATIONAL EDUCATION;

ADULT; AGED; AGED, 80 AND OVER; CORONARY CARE UNITS; FAMILY PRACTICE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT ADMISSION; QUESTIONNAIRES; REFERRAL AND CONSULTATION; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 0346442700     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. De Bono DP, Hopkins A. The management of acute myocardial infarction: guidelines and audit standards. Report of a workshop of the joint audit committee of the British Cardiac Society and the Royal College of Physicians. J Roy Coll Physicians London 1994;28:312-7.
2. GREAT Group. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian Region early anistreplase trial. Br Med J 1992;305:548-53.
3. MacCallam AG, Stafford PJ, Jones C, Vincent R, et al. Reduction in hospital time to thrombolytic therapy by audit of policy guidelines. Eur Heart J 1990;11:48-52.
4. Pell AC, Miller HC, Robertson CE, Fox KA. Effect of 'fast track' admission for myocardial infarction on delay to thrombolysis. Br Med J 1992;304:83-7.
5. Ranjadayalan K, Umachandran V, Timmis A. 'Fast track' admission for acute myocardial infarction. Br Med J 1992;304:380.
6. Burns JMA, Hogg KJ, Rae AP, Hillis WS, Dunn FG. Impact of a policy of direct admission to a coronary care unit on use of thrombolytic treatment. Br Heart J 1989;61:322-5.
7. Cragg DR, Friedman HZ, Bonema JD, Jaiyesmi IA, et al. Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy. Ann Intern Med 1991;115:173-7.
8. French JK, Williams BF, Hart HH, Wyatt S, et al. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. Br Med J 1996;312:1637-41.
9. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-85.
10. Gruppo Italiano per Io Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic therapy in acute myocardial infarction. Lancet 1986;i:397-402.
11. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;ii:349-60.
12. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1,000 patients. Lancet 1994;343:311-22.
13. Catnach S, Pinkney J, Woods A, Fairclough P. 'Fast track' admission for acute myocardial infarction. Br Med J 1992;304:380-1.
14. Hearn I. General practice at night. Br Med J 1995;311:466.